Catechol-O-Methyltransferase Inhibitor [EPC]

Catechol-O-Methyltransferase Inhibitor [EPC] was reported 5038 times

Drugs of the Catechol-O-Methyltransferase Inhibitor [EPC] class are most commonly taken among patients reporting these side effects:

# Drug class Count Frequency
0 DYSKINESIA HYPERPYREXIA SYNDROME 7 0.1489
1 INFUSION SITE HYPERTROPHY 4 0.1429
2 DOPAMINE AGONIST WITHDRAWAL SYNDROME 7 0.1296
3 INFUSION SITE PAPULE 10 0.1053
4 DOPAMINE DYSREGULATION SYNDROME 45 0.1009
5 PARKINSONISM HYPERPYREXIA SYNDROME 17 0.0950
6 REDUCED FACIAL EXPRESSION 90 0.0887
7 ON AND OFF PHENOMENON 478 0.0860
8 CATHETER SITE INDURATION 15 0.0777
9 JEALOUS DELUSION 21 0.0742
10 PARKINSONIAN GAIT 46 0.0737
11 HYPERKINESIA 145 0.0683
12 FREEZING PHENOMENON 248 0.0669
13 CAMPTOCORMIA 16 0.0667
14 PROGRESSIVE SUPRANUCLEAR PALSY 13 0.0647
15 DEEP BRAIN STIMULATION 37 0.0613
16 CATHETER SITE NODULE 11 0.0576
17 STOMA SITE IRRITATION 25 0.0460
18 INFUSION SITE ABSCESS 23 0.0456
19 STOMA SITE EXTRAVASATION 17 0.0440
20 STOMA SITE DISCHARGE 115 0.0420
21 STOMA SITE ERYTHEMA 77 0.0412
22 AKINESIA 85 0.0410
23 SOMATIC DELUSION 10 0.0407
24 CATHETER SITE MASS 6 0.0395
25 DRUG THERAPEUTIC INCOMPATIBILITY 6 0.0390
26 STOMA SITE REACTION 26 0.0380
27 STOMA SITE PAIN 54 0.0367
28 STOMA SITE HYPERGRANULATION 23 0.0365
29 CATHETER SITE BRUISE 12 0.0363
30 STOMA SITE INFLAMMATION 27 0.0361
31 STOMA SITE DISCOMFORT 8 0.0352
32 DYSDIADOCHOKINESIS 6 0.0351
33 STEREOTYPY 33 0.0350
34 INFUSION SITE INDURATION 49 0.0330
35 HYPERSEXUALITY 60 0.0328
36 BRADYKINESIA 193 0.0327
37 RESTING TREMOR 21 0.0325
38 PATHOLOGICAL GAMBLING 52 0.0313
39 STOMA SITE ODOUR 7 0.0312
40 ACTION TREMOR 5 0.0309
41 STOMA SITE INFECTION 40 0.0307
42 SALIVA DISCOLOURATION 10 0.0299
43 INFUSION SITE HAEMATOMA 14 0.0294
44 STOMA SITE ABSCESS 7 0.0288
45 INSULIN C-PEPTIDE INCREASED 4 0.0288
46 CATHETER SITE IRRITATION 9 0.0270
47 FIBROMA 24 0.0261
48 IMPULSE-CONTROL DISORDER 53 0.0257
49 SALIVA ALTERED 23 0.0256
50 INTENTIONAL MEDICAL DEVICE REMOVAL BY PATIENT 24 0.0238
51 THERAPEUTIC PRODUCT EFFECT VARIABLE 89 0.0229
52 INFUSION SITE NODULE 22 0.0229
53 ENTERAL NUTRITION 13 0.0224
54 EUTHANASIA 7 0.0221
55 SLEEP ATTACKS 10 0.0210
56 DYSKINESIA 849 0.0209
57 MUSCLE RIGIDITY 242 0.0202
58 DELUSIONAL DISORDER, UNSPECIFIED TYPE 15 0.0201
59 INFUSION SITE INFLAMMATION 14 0.0198
60 SOFT TISSUE MASS 9 0.0195
61 HALLUCINATION, OLFACTORY 8 0.0184
62 COMPULSIVE SHOPPING 37 0.0180
63 DROPPED HEAD SYNDROME 7 0.0177
64 PARKINSON'S DISEASE 45 0.0177
65 POSTURAL TREMOR 5 0.0171
66 SUSPICIOUSNESS 12 0.0171
67 CATHETER SITE HAEMATOMA 5 0.0169
68 STOMA COMPLICATION 17 0.0167
69 MUTISM 24 0.0165
70 GAMBLING 19 0.0163
71 HYPERMOBILITY SYNDROME 8 0.0161
72 CATHETER SITE RELATED REACTION 12 0.0160
73 SUDDEN ONSET OF SLEEP 22 0.0159
74 GASTRIC FISTULA 7 0.0157
75 STOMA SITE HAEMORRHAGE 24 0.0156
76 HALLUCINATION, VISUAL 324 0.0153
77 INFUSION SITE CELLULITIS 8 0.0152
78 SEXUALLY INAPPROPRIATE BEHAVIOUR 7 0.0150
79 ACUTE PSYCHOSIS 37 0.0149
80 RAPID EYE MOVEMENT SLEEP BEHAVIOUR DISORDER 6 0.0149
81 DEVICE COLOUR ISSUE 6 0.0149
82 INFUSION SITE MASS 16 0.0147
83 REHABILITATION THERAPY 56 0.0144
84 PLEUROTHOTONUS 13 0.0144
85 POSTURE ABNORMAL 46 0.0141
86 INCREASED DOSE ADMINISTERED 4 0.0128
87 DELUSION 197 0.0127
88 PRODUCT RESIDUE PRESENT 68 0.0126
89 MASKED FACIES 5 0.0123
90 HALLUCINATION 909 0.0120
91 WRONG PATIENT 6 0.0120
92 DEVICE ALARM ISSUE 21 0.0116
93 ILLUSION 19 0.0115
94 INFUSION SITE WARMTH 14 0.0114
95 EXPULSION OF MEDICATION 6 0.0113
96 TORTICOLLIS 24 0.0113
97 DELUSION OF GRANDEUR 5 0.0111
98 DYSTONIA 215 0.0111
99 DEVICE CONNECTION ISSUE 23 0.0109
100 CATHETER SITE DISCHARGE 12 0.0107
101 MEDICAL DEVICE SITE PAIN 6 0.0107
102 PERSECUTORY DELUSION 26 0.0104
103 INFUSION SITE REACTION 31 0.0104
104 LABELLED DRUG-FOOD INTERACTION MEDICATION ERROR 5 0.0100
105 YAWNING 26 0.0097
106 DEVICE KINK 35 0.0096
107 RECALL PHENOMENON 8 0.0096
108 BEZOAR 13 0.0094
109 MEDICAL DEVICE CHANGE 5 0.0094
110 CHOREA 16 0.0093
111 DEVICE LOOSENING 8 0.0092
112 HYPOKINESIA 134 0.0092
113 URGE INCONTINENCE 8 0.0092
114 WRONG DEVICE USED 6 0.0091
115 DRUG EFFECT VARIABLE 10 0.0088
116 MEDICAL DEVICE SITE DISCOMFORT 7 0.0087
117 HALLUCINATIONS, MIXED 36 0.0086
118 GAMBLING DISORDER 23 0.0085
119 OROMANDIBULAR DYSTONIA 6 0.0082
120 BLOOD URIC ACID DECREASED 4 0.0082
121 DEMENTIA WITH LEWY BODIES 9 0.0081
122 FOOD REFUSAL 7 0.0080
123 LIVING IN RESIDENTIAL INSTITUTION 15 0.0080
124 INFUSION SITE DISCHARGE 14 0.0080
125 DEVICE OCCLUSION 110 0.0078
126 COGWHEEL RIGIDITY 8 0.0076
127 FINE MOTOR SKILL DYSFUNCTION 22 0.0076
128 BINGE EATING 8 0.0074
129 BEHAVIOUR DISORDER 40 0.0074
130 EXECUTIVE DYSFUNCTION 4 0.0074
131 IMPULSIVE BEHAVIOUR 27 0.0072
132 IMMOBILE 31 0.0071
133 SLEEP TALKING 12 0.0071
134 ORTHOSTATIC INTOLERANCE 5 0.0070
135 INFUSION SITE BRUISING 15 0.0069
136 SOLILOQUY 6 0.0069
137 ANTICHOLINERGIC SYNDROME 11 0.0069
138 ORTHOSTATIC HYPOTENSION 120 0.0069
139 DIET REFUSAL 5 0.0068
140 HYPOMANIA 25 0.0068
141 FLUID INTAKE REDUCED 34 0.0068
142 TENSION 41 0.0067
143 DISORGANISED SPEECH 12 0.0065
144 CREATINE KINASE INCREASED 5 0.0065
145 AUTONOMIC NERVOUS SYSTEM IMBALANCE 19 0.0065
146 STREPTOCOCCAL BACTERAEMIA 7 0.0064
147 INFUSION SITE ERYTHEMA 54 0.0064
148 BLADDER CATHETERISATION 6 0.0062
149 FEAR OF FALLING 5 0.0061
150 LOGORRHOEA 21 0.0060
151 HEAT ILLNESS 4 0.0059
152 THERAPEUTIC RESPONSE SHORTENED 196 0.0059
153 INFUSION SITE DISCOMFORT 6 0.0058
154 CONSCIOUSNESS FLUCTUATING 6 0.0057
155 INFUSION SITE DISCOLOURATION 5 0.0057
156 FEMORAL NECK FRACTURE 29 0.0057
157 INFREQUENT BOWEL MOVEMENTS 14 0.0056
158 INFUSION SITE INFECTION 13 0.0056
159 THERAPEUTIC PRODUCT EFFECT DELAYED 25 0.0055
160 NONSPECIFIC REACTION 30 0.0055
161 NOCTURIA 65 0.0053
162 PSYCHOTIC DISORDER 157 0.0053
163 COLITIS MICROSCOPIC 25 0.0053
164 NEUROLEPTIC MALIGNANT SYNDROME 62 0.0052
165 DISCOLOURED VOMIT 5 0.0052
166 OBSESSIVE-COMPULSIVE DISORDER 41 0.0051
167 FOOD INTERACTION 9 0.0051
168 TERMINAL INSOMNIA 9 0.0051
169 NASAL DISCHARGE DISCOLOURATION 7 0.0051
170 CATHETER SITE PAIN 13 0.0050
171 DISINHIBITION 8 0.0050
172 EXCESSIVE GRANULATION TISSUE 4 0.0050
173 LIBIDO INCREASED 10 0.0049
174 PNEUMOPERITONEUM 9 0.0049
175 DEMENTIA 136 0.0049
176 CATHETER SITE ERYTHEMA 10 0.0047
177 PALLIATIVE CARE 7 0.0046
178 INFUSION SITE HAEMORRHAGE 15 0.0046
179 OBSESSIVE THOUGHTS 8 0.0044
180 MOTOR DYSFUNCTION 45 0.0044
181 PARANOIA 76 0.0044
182 CATHETER SITE HAEMORRHAGE 11 0.0044
183 FOLATE DEFICIENCY 5 0.0043
184 ABULIA 4 0.0043
185 SHOULDER FRACTURE 7 0.0043
186 DELIRIUM 147 0.0042
187 LANGUAGE DISORDER 9 0.0042
188 DYSCHEZIA 12 0.0039
189 GASTROINTESTINAL STOMA COMPLICATION 6 0.0038
190 SLEEP DEFICIT 8 0.0038
191 CERVICAL VERTEBRAL FRACTURE 13 0.0038
192 SLOW SPEECH 9 0.0037
193 INTENTIONAL UNDERDOSE 27 0.0037
194 DISCHARGE 5 0.0036
195 MOBILITY DECREASED 257 0.0036
196 ENERGY INCREASED 21 0.0036
197 GAZE PALSY 6 0.0035
198 CEREBRAL ATROPHY 14 0.0035
199 SALIVARY HYPERSECRETION 35 0.0035
200 DILATATION ATRIAL 4 0.0034
201 DEVICE POWER SOURCE ISSUE 10 0.0034
202 INITIAL INSOMNIA 35 0.0034
203 COGNITIVE DISORDER 159 0.0034
204 AGGRESSION 170 0.0034
205 VOLVULUS 8 0.0034
206 PRODUCT CLEANING INADEQUATE 9 0.0034
207 APRAXIA 5 0.0034
208 DEVICE DISLOCATION 146 0.0034
209 PNEUMONIA ASPIRATION 83 0.0033
210 CLUMSINESS 9 0.0033
211 POOR QUALITY SLEEP 71 0.0033
212 ABNORMAL DREAMS 91 0.0033
213 PARKINSONISM 32 0.0033
214 HYPERTHERMIA 25 0.0033
215 DEVICE USE ISSUE 57 0.0033
216 DAYDREAMING 5 0.0032
217 GAIT INABILITY 108 0.0032
218 SMALL INTESTINAL PERFORATION 6 0.0032
219 PANIC REACTION 23 0.0032
220 MICTURITION DISORDER 11 0.0032
221 FACE INJURY 12 0.0032
222 WHEELCHAIR USER 14 0.0031
223 SPEECH DISORDER 165 0.0031
224 MOVEMENT DISORDER 101 0.0031
225 TERMINAL STATE 21 0.0031
226 PSYCHOMOTOR HYPERACTIVITY 52 0.0031
227 INFUSION SITE IRRITATION 4 0.0031
228 RESTLESSNESS 114 0.0031
229 MANIA 50 0.0030
230 INFUSION SITE PAIN 39 0.0030
231 QUADRIPARESIS 5 0.0030
232 BOWEL MOVEMENT IRREGULARITY 23 0.0030
233 BALANCE DISORDER 256 0.0030
234 MEDICAL DEVICE DISCOMFORT 9 0.0029
235 INJECTION SITE NECROSIS 6 0.0029
236 JOINT DISLOCATION 31 0.0029
237 CATHETER SITE INFECTION 11 0.0029
238 SPINAL STENOSIS 12 0.0029
239 BENIGN PROSTATIC HYPERPLASIA 15 0.0029
240 WALKING AID USER 19 0.0029
241 THROMBOPHLEBITIS 10 0.0028
242 HALLUCINATION, AUDITORY 45 0.0028
243 FACIAL PARESIS 10 0.0028
244 INTENSIVE CARE 4 0.0028
245 MEDICAL DEVICE PAIN 6 0.0028
246 DEVICE PLACEMENT ISSUE 10 0.0028
247 TREMOR 457 0.0028
248 SOMNAMBULISM 18 0.0027
249 FAECALOMA 15 0.0027
250 NEGATIVE THOUGHTS 8 0.0027
251 ABNORMAL BEHAVIOUR 108 0.0027
252 SUBSTANCE-INDUCED PSYCHOTIC DISORDER 6 0.0027
253 PRODUCT PACKAGING DIFFICULT TO OPEN 7 0.0027
254 HYPOSMIA 4 0.0027
255 DEVICE ISSUE 232 0.0026
256 DYSGRAPHIA 17 0.0026
257 DECUBITUS ULCER 21 0.0026
258 CONFUSIONAL STATE 416 0.0026
259 ATROPHY 5 0.0026
260 PELVIC FRACTURE 20 0.0026
261 FALL 854 0.0026
262 ABDOMINAL WALL HAEMATOMA 5 0.0026
263 INFUSION SITE SWELLING 16 0.0025
264 HYPOPHAGIA 65 0.0025
265 HOSPICE CARE 25 0.0025
266 SPUTUM DISCOLOURED 24 0.0025
267 AGITATION 184 0.0025
268 DEVICE PHYSICAL PROPERTY ISSUE 19 0.0025
269 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 175 0.0025
270 HIP FRACTURE 79 0.0025
271 PSYCHOTIC SYMPTOM 5 0.0024
272 INJECTION SITE ABSCESS 6 0.0024
273 SUBILEUS 5 0.0024
274 LUMBAR VERTEBRAL FRACTURE 11 0.0024
275 SKIN MASS 16 0.0024
276 DEVICE MATERIAL ISSUE 5 0.0024
277 SCREAMING 15 0.0024
278 OCULOGYRIC CRISIS 5 0.0023
279 NIGHTMARE 80 0.0023
280 SEROTONIN SYNDROME 44 0.0023
281 DEPRESSIVE SYMPTOM 8 0.0023
282 CORONAVIRUS INFECTION 15 0.0023
283 GAIT DISTURBANCE 434 0.0023
284 SCOLIOSIS 14 0.0023
285 CHOKING 44 0.0023
286 RESTLESS LEGS SYNDROME 41 0.0023
287 GASTROINTESTINAL ULCER 5 0.0023
288 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 107 0.0022
289 DISORIENTATION 88 0.0022
290 ANOSMIA 32 0.0022
291 MUSCULOSKELETAL STIFFNESS 191 0.0022
292 INCONTINENCE 23 0.0022
293 HYPERTENSIVE HEART DISEASE 4 0.0021
294 INFECTED SKIN ULCER 4 0.0021
295 SKIN LACERATION 23 0.0021
296 DYSPHAGIA 199 0.0021
297 WEIGHT ABNORMAL 5 0.0021
298 STARING 5 0.0021
299 PANIC DISORDER 8 0.0021
300 FAECES HARD 8 0.0021
301 LUMBAR SPINAL STENOSIS 6 0.0021
302 BRUXISM 11 0.0020
303 URINARY RETENTION 68 0.0020
304 DROOLING 14 0.0020
305 HEAD INJURY 64 0.0020
306 DIPLEGIA 4 0.0020
307 TACHYPHRENIA 7 0.0020
308 ILEUS 25 0.0020
309 MIDDLE INSOMNIA 37 0.0020
310 EAR HAEMORRHAGE 4 0.0020
311 UNRESPONSIVE TO STIMULI 51 0.0020
312 DEPRESSED MOOD 104 0.0020
313 DEPRESSED LEVEL OF CONSCIOUSNESS 77 0.0019
314 CACHEXIA 10 0.0019
315 DYSARTHRIA 73 0.0019
316 SLEEP DISORDER 136 0.0019
317 MICTURITION URGENCY 22 0.0019
318 ASPIRATION 21 0.0019
319 INFUSION SITE PRURITUS 6 0.0019
320 PSYCHIATRIC SYMPTOM 14 0.0019
321 HYPERPYREXIA 8 0.0019
322 UPPER LIMB FRACTURE 37 0.0019
323 HIP SURGERY 10 0.0018
324 ABDOMINAL RIGIDITY 5 0.0018
325 ABNORMAL FAECES 15 0.0018
326 INJECTION SITE INFECTION 6 0.0018
327 INGUINAL HERNIA 11 0.0018
328 POLYNEUROPATHY 21 0.0018
329 BEDRIDDEN 23 0.0017
330 TRISMUS 9 0.0017
331 GENERAL SYMPTOM 13 0.0017
332 VITAMIN B12 DEFICIENCY 7 0.0017
333 PERSONALITY CHANGE 16 0.0017
334 QUALITY OF LIFE DECREASED 23 0.0017
335 CATATONIA 9 0.0017
336 DISCOURAGEMENT 4 0.0017
337 HYPERSOMNIA 49 0.0017
338 PRESCRIBED UNDERDOSE 34 0.0017
339 RIB FRACTURE 35 0.0017
340 PRODUCT COMMUNICATION ISSUE 15 0.0017
341 INCOHERENT 11 0.0017
342 SOMNOLENCE 335 0.0017
343 DIABETES INSIPIDUS 4 0.0017
344 EMBEDDED DEVICE 16 0.0016
345 GASTROINTESTINAL TUBE INSERTION 4 0.0016
346 DYSPHEMIA 7 0.0016
347 UNEVALUABLE EVENT 120 0.0016
348 FORMICATION 11 0.0016
349 TROPONIN INCREASED 12 0.0016
350 DRY THROAT 16 0.0016
351 ABDOMINAL INFECTION 4 0.0016
352 THERAPEUTIC PRODUCT EFFECT DECREASED 70 0.0016
353 SENSORY DISTURBANCE 25 0.0016
354 ANAL INCONTINENCE 14 0.0016
355 GENERAL PHYSICAL HEALTH DETERIORATION 179 0.0015
356 FAILURE TO THRIVE 8 0.0015
357 FOOT DEFORMITY 17 0.0015
358 MALABSORPTION 8 0.0015
359 APHASIA 46 0.0015
360 LISTLESS 5 0.0015
361 BLOOD PRESSURE FLUCTUATION 36 0.0015
362 CONSTIPATION 325 0.0015
363 DRUG EFFECT LESS THAN EXPECTED 22 0.0015
364 DYSSTASIA 43 0.0015
365 GASTRIC PERFORATION 4 0.0015
366 HYPOPNOEA 5 0.0014
367 APATHY 21 0.0014
368 DYSPHONIA 84 0.0014
369 ANAL HAEMORRHAGE 4 0.0014
370 ENDOTRACHEAL INTUBATION 4 0.0014
371 MUSCLE CONTRACTIONS INVOLUNTARY 5 0.0014
372 INFLAMMATORY MARKER INCREASED 7 0.0014
373 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 24 0.0014
374 LIMB DISCOMFORT 43 0.0014
375 FIBULA FRACTURE 4 0.0014
376 NASAL DISCOMFORT 11 0.0014
377 REFUSAL OF TREATMENT BY PATIENT 9 0.0014
378 BRADYPHRENIA 9 0.0014
379 HYPOVOLAEMIA 8 0.0014
380 ORAL DISCOMFORT 19 0.0014
381 EUPHORIC MOOD 14 0.0014
382 INJECTION SITE NODULE 15 0.0014
383 URINARY TRACT INFECTION 228 0.0013
384 TREATMENT NONCOMPLIANCE 73 0.0013
385 SPINAL COMPRESSION FRACTURE 11 0.0013
386 FOOD CRAVING 7 0.0013
387 SUBDURAL HAEMATOMA 19 0.0013
388 DRUG EFFECT DELAYED 6 0.0013
389 CRANIOCEREBRAL INJURY 4 0.0013
390 URINE ABNORMALITY 6 0.0013
391 EYE INJURY 4 0.0013
392 EATING DISORDER 28 0.0013
393 LIGAMENT SPRAIN 13 0.0013
394 GASTROINTESTINAL MOTILITY DISORDER 7 0.0013
395 FEAR 35 0.0013
396 UROSEPSIS 12 0.0013
397 GASTRITIS EROSIVE 6 0.0013
398 MEMORY IMPAIRMENT 175 0.0013
399 SKIN ABRASION 6 0.0013
400 CHOKING SENSATION 7 0.0013
401 BLADDER PAIN 4 0.0013
402 MALNUTRITION 14 0.0013
403 LIMB OPERATION 6 0.0012
404 MOOD ALTERED 34 0.0012
405 DISTURBANCE IN ATTENTION 67 0.0012
406 DIZZINESS POSTURAL 12 0.0012
407 PRODUCT ADMINISTRATION ERROR 25 0.0012
408 DEVICE BREAKAGE 50 0.0012
409 PERIPHERAL VENOUS DISEASE 5 0.0012
410 OROPHARYNGEAL DISCOMFORT 11 0.0012
411 PRODUCT PRESCRIBING ERROR 29 0.0012
412 URINARY INCONTINENCE 36 0.0012
413 FOOT OPERATION 6 0.0012
414 UNINTENTIONAL MEDICAL DEVICE REMOVAL 14 0.0012
415 MUSCULOSKELETAL DISORDER 23 0.0012
416 BLOOD PRESSURE ABNORMAL 24 0.0012
417 PRODUCT USE COMPLAINT 19 0.0012
418 MENTAL DISORDER 52 0.0012
419 SLEEP TERROR 5 0.0012
420 BLOOD CREATINE PHOSPHOKINASE INCREASED 34 0.0012
421 MUSCLE FATIGUE 5 0.0012
422 PETIT MAL EPILEPSY 6 0.0012
423 CARDIAC FAILURE CHRONIC 5 0.0012
424 PRODUCT DISPENSING ISSUE 5 0.0012
425 TENSION HEADACHE 5 0.0012
426 HYPERREFLEXIA 4 0.0011
427 DEVICE DIFFICULT TO USE 76 0.0011
428 AFFECTIVE DISORDER 9 0.0011
429 PRODUCT PHYSICAL ISSUE 23 0.0011
430 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 53 0.0011
431 INTENTIONAL DEVICE MISUSE 5 0.0011
432 COMPRESSION FRACTURE 6 0.0011
433 PANCREATITIS ACUTE 25 0.0011
434 FRACTURE 21 0.0011
435 ASPHYXIA 9 0.0011
436 BLOOD PRESSURE DECREASED 73 0.0011
437 WOUND INFECTION 12 0.0011
438 JAW DISORDER 6 0.0011
439 INJECTION SITE PAPULE 5 0.0011
440 EYE OPERATION 5 0.0011
441 ARTHRITIS INFECTIVE 5 0.0011
442 CYSTITIS 34 0.0011
443 DEVICE LEAKAGE 46 0.0011
444 ADVERSE DRUG REACTION 95 0.0011
445 SPINAL OPERATION 13 0.0011
446 DRY MOUTH 85 0.0010
447 SUDDEN DEATH 11 0.0010
448 SOCIAL AVOIDANT BEHAVIOUR 6 0.0010
449 HYPERVENTILATION 6 0.0010
450 ABNORMAL LOSS OF WEIGHT 7 0.0010
451 CARDIOPULMONARY FAILURE 4 0.0010
452 CHROMATURIA 23 0.0010
453 DECREASED INTEREST 6 0.0010
454 CATARACT OPERATION 6 0.0010
455 CARDIAC PACEMAKER INSERTION 6 0.0010
456 HYPERPHAGIA 4 0.0010
457 DIPLOPIA 26 0.0010
458 IRRITABILITY 60 0.0010
459 NODULE 13 0.0010
460 DUODENAL ULCER 7 0.0010
461 MENTAL IMPAIRMENT 24 0.0010
462 DYSPHORIA 5 0.0010
463 MUSCLE TIGHTNESS 16 0.0010
464 SARS-COV-2 TEST POSITIVE 13 0.0010
465 INSOMNIA 262 0.0010
466 SLUGGISHNESS 10 0.0010
467 ENCEPHALOPATHY 24 0.0010
468 PRODUCT COLOUR ISSUE 5 0.0010
469 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 10 0.0010
470 ALTERED STATE OF CONSCIOUSNESS 21 0.0010
471 GENERALISED TONIC-CLONIC SEIZURE 16 0.0010
472 ANXIETY 275 0.0010
473 PARTIAL SEIZURES 5 0.0010
474 MUSCLE TWITCHING 22 0.0010
475 SENSITIVITY TO WEATHER CHANGE 5 0.0009
476 SENSATION OF FOREIGN BODY 8 0.0009
477 UNDERDOSE 69 0.0009
478 AORTIC VALVE INCOMPETENCE 4 0.0009
479 FACIAL PARALYSIS 8 0.0009
480 FEEDING DISORDER 19 0.0009
481 MYDRIASIS 12 0.0009
482 PRESCRIBED OVERDOSE 18 0.0009
483 MYOPATHY 8 0.0009
484 HAEMODYNAMIC INSTABILITY 7 0.0009
485 PRODUCT PRESCRIBING ISSUE 20 0.0009
486 WRIST FRACTURE 11 0.0009
487 INCORRECT DOSE ADMINISTERED BY DEVICE 24 0.0009
488 KNEE OPERATION 9 0.0009
489 HIP ARTHROPLASTY 14 0.0009
490 THINKING ABNORMAL 17 0.0009
491 INTESTINAL ISCHAEMIA 5 0.0009
492 GASTRIC ULCER HAEMORRHAGE 5 0.0009
493 GASTRIC ULCER 17 0.0009
494 TRANSIENT ISCHAEMIC ATTACK 30 0.0009
495 EMOTIONAL DISORDER 27 0.0009
496 RESPIRATION ABNORMAL 6 0.0009
497 SHOCK 20 0.0009
498 MENTAL STATUS CHANGES 24 0.0009
499 PRODUCT DISTRIBUTION ISSUE 8 0.0009
500 NERVOUSNESS 45 0.0009
501 LOSS OF CONSCIOUSNESS 110 0.0009
502 FEELING OF DESPAIR 4 0.0009
503 DRUG INTERACTION 136 0.0009
504 POLYURIA 7 0.0009
505 HAND FRACTURE 6 0.0008
506 BODY HEIGHT DECREASED 9 0.0008
507 PARALYSIS 12 0.0008
508 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 8 0.0008
509 THERAPY CESSATION 43 0.0008
510 WEIGHT DECREASED 233 0.0008
511 HYPONATRAEMIA 47 0.0008
512 CONDITION AGGRAVATED 252 0.0008
513 GUILLAIN-BARRE SYNDROME 4 0.0008
514 FAECES SOFT 6 0.0008
515 DRUG EFFECT DECREASED 44 0.0008
516 ABSCESS 13 0.0008
517 MUSCLE STRAIN 7 0.0008
518 FEELING DRUNK 6 0.0008
519 FEMUR FRACTURE 25 0.0008
520 GASTROINTESTINAL SOUNDS ABNORMAL 4 0.0008
521 IMPAIRED GASTRIC EMPTYING 11 0.0008
522 INJECTION SITE INFLAMMATION 4 0.0008
523 HYPERNATRAEMIA 4 0.0008
524 MUSCULAR WEAKNESS 91 0.0008
525 BRAIN INJURY 8 0.0008
526 PAROSMIA 6 0.0008
527 MITRAL VALVE INCOMPETENCE 9 0.0008
528 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 7 0.0008
529 HYPOTHERMIA 8 0.0008
530 HOSPITALISATION 120 0.0008
531 ROTATOR CUFF SYNDROME 10 0.0008
532 INTERVERTEBRAL DISC PROTRUSION 17 0.0008
533 CEREBRAL ISCHAEMIA 4 0.0008
534 APNOEA 6 0.0008
535 TENDON DISORDER 5 0.0008
536 BRAIN FOG 12 0.0008
537 FEELING ABNORMAL 182 0.0008
538 BLOOD LACTIC ACID INCREASED 4 0.0008
539 MYOCLONUS 9 0.0008
540 APPETITE DISORDER 5 0.0008
541 MALIGNANT MELANOMA 10 0.0007
542 ASTHENIA 280 0.0007
543 DECREASED ACTIVITY 8 0.0007
544 POSTOPERATIVE WOUND INFECTION 5 0.0007
545 HYPERHIDROSIS 95 0.0007
546 THERAPEUTIC RESPONSE UNEXPECTED 33 0.0007
547 HEAD DISCOMFORT 13 0.0007
548 DEVICE DELIVERY SYSTEM ISSUE 20 0.0007
549 EXTRAPYRAMIDAL DISORDER 18 0.0007
550 HYPOTENSION 145 0.0007
551 RHABDOMYOLYSIS 30 0.0007
552 COUGH 200 0.0007
553 ANGER 24 0.0007
554 DEPRESSION 160 0.0007
555 SYNCOPE 70 0.0007
556 IMPAIRED QUALITY OF LIFE 10 0.0007
557 LETHARGY 40 0.0007
558 PYELONEPHRITIS 6 0.0007
559 TONGUE DISORDER 5 0.0007
560 EPILEPSY 21 0.0007
561 PANIC ATTACK 25 0.0007
562 FOOT FRACTURE 13 0.0007
563 CONTUSION 66 0.0007
564 MAJOR DEPRESSION 5 0.0007
565 GRIP STRENGTH DECREASED 6 0.0007
566 INCREASED APPETITE 13 0.0007
567 DEHYDRATION 90 0.0007
568 SKIN HAEMORRHAGE 10 0.0007
569 VENTRICULAR EXTRASYSTOLES 7 0.0007
570 POLLAKIURIA 28 0.0007
571 MACULAR DEGENERATION 8 0.0007
572 HYPERLIPIDAEMIA 8 0.0007
573 WEIGHT FLUCTUATION 7 0.0007
574 THROAT IRRITATION 30 0.0007
575 DIZZINESS 332 0.0007
576 MUSCLE SPASMS 122 0.0007
577 DECREASED APPETITE 154 0.0007
578 TACHYPNOEA 9 0.0007
579 PNEUMONIA 214 0.0007
580 AKATHISIA 9 0.0007
581 HAEMATOMA 17 0.0007
582 PNEUMONIA BACTERIAL 6 0.0007
583 SEDATION 17 0.0006
584 GASTRITIS 17 0.0006
585 CONCUSSION 5 0.0006
586 CARPAL TUNNEL SYNDROME 9 0.0006
587 DEATH 552 0.0006
588 SECRETION DISCHARGE 8 0.0006
589 LACERATION 6 0.0006
590 ELECTROCARDIOGRAM ABNORMAL 5 0.0006
591 CARDIOVASCULAR DISORDER 16 0.0006
592 COMA 30 0.0006
593 TRICUSPID VALVE INCOMPETENCE 5 0.0006
594 CONTRAINDICATED PRODUCT ADMINISTERED 19 0.0006
595 ATRIAL FLUTTER 5 0.0006
596 SKIN INFECTION 7 0.0006
597 ACUTE RESPIRATORY FAILURE 12 0.0006
598 MIOSIS 5 0.0006
599 PRODUCT DOSE OMISSION ISSUE 180 0.0006
600 UPPER-AIRWAY COUGH SYNDROME 5 0.0006
601 BLADDER DISORDER 6 0.0006
602 EXPIRED PRODUCT ADMINISTERED 20 0.0006
603 AGEUSIA 15 0.0006
604 DYSURIA 22 0.0006
605 PERIPHERAL SWELLING 92 0.0006
606 SUICIDE ATTEMPT 36 0.0006
607 ARRHYTHMIA 28 0.0006
608 EYELID PTOSIS 6 0.0006
609 EYE MOVEMENT DISORDER 4 0.0006
610 PRODUCT DOSE OMISSION 38 0.0006
611 RESPIRATORY DISTRESS 16 0.0006
612 COORDINATION ABNORMAL 8 0.0006
613 SPINAL OSTEOARTHRITIS 5 0.0006
614 JOINT INJURY 12 0.0006
615 MALAISE 246 0.0006
616 CELLULITIS 28 0.0006
617 HAEMATOCRIT DECREASED 11 0.0006
618 LEUKOCYTOSIS 10 0.0006
619 LIMB INJURY 15 0.0006
620 PULMONARY THROMBOSIS 6 0.0005
621 WHITE BLOOD CELL COUNT INCREASED 21 0.0005
622 GASTROINTESTINAL PAIN 6 0.0005
623 IRON DEFICIENCY ANAEMIA 5 0.0005
624 CARDIAC FAILURE 43 0.0005
625 APPENDICITIS 5 0.0005
626 DEFORMITY 5 0.0005
627 HYPOTHYROIDISM 17 0.0005
628 BLOOD SODIUM DECREASED 10 0.0005
629 CIRCULATORY COLLAPSE 9 0.0005
630 DERMATITIS CONTACT 6 0.0005
631 SUICIDAL IDEATION 48 0.0005
632 BLOOD ALKALINE PHOSPHATASE INCREASED 13 0.0005
633 AMNESIA 34 0.0005
634 GASTRIC HAEMORRHAGE 6 0.0005
635 LOWER LIMB FRACTURE 10 0.0005
636 NECK PAIN 29 0.0005
637 ATRIAL FIBRILLATION 50 0.0005
638 COLD SWEAT 9 0.0005
639 ILL-DEFINED DISORDER 31 0.0005
640 CARDIAC ARREST 42 0.0005
641 THERAPY CHANGE 5 0.0005
642 PNEUMOTHORAX 8 0.0005
643 BLOOD ALBUMIN DECREASED 4 0.0005
644 CEREBRAL HAEMORRHAGE 18 0.0005
645 APHONIA 7 0.0005
646 DRUG INTOLERANCE 48 0.0005
647 TARDIVE DYSKINESIA 14 0.0005
648 FRUSTRATION TOLERANCE DECREASED 4 0.0005
649 PRODUCT DOSE OMISSION IN ERROR 14 0.0005
650 DISCOMFORT 30 0.0005
651 DEVICE USE ERROR 17 0.0005
652 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 99 0.0005
653 HICCUPS 4 0.0005
654 SEIZURE 56 0.0005
655 TOOTH EXTRACTION 6 0.0005
656 BLOOD UREA INCREASED 8 0.0005
657 INTESTINAL OBSTRUCTION 18 0.0005
658 ABDOMINAL PAIN LOWER 12 0.0005
659 GASTROINTESTINAL DISORDER 42 0.0005
660 THERAPY NON-RESPONDER 21 0.0005
661 WOUND 13 0.0005
662 INJECTION SITE INDURATION 6 0.0005
663 DEVICE DEFECTIVE 8 0.0005
664 HYPOAESTHESIA 69 0.0005
665 PRODUCTIVE COUGH 22 0.0005
666 RESPIRATORY TRACT INFECTION 12 0.0005
667 BACK INJURY 5 0.0005
668 ILLNESS 47 0.0005
669 LOCALISED INFECTION 11 0.0005
670 DEVICE RELATED INFECTION 7 0.0005
671 MUSCULOSKELETAL CHEST PAIN 7 0.0005
672 DENTAL CARIES 5 0.0005
673 RED BLOOD CELL SEDIMENTATION RATE INCREASED 5 0.0005
674 OEDEMA PERIPHERAL 55 0.0005
675 FATIGUE 351 0.0005
676 TACHYCARDIA 40 0.0004
677 INTENTIONAL SELF-INJURY 9 0.0004
678 VISUAL IMPAIRMENT 55 0.0004
679 BODY TEMPERATURE INCREASED 9 0.0004
680 C-REACTIVE PROTEIN INCREASED 16 0.0004
681 RESPIRATORY FAILURE 32 0.0004
682 PERIPHERAL COLDNESS 6 0.0004
683 BRADYCARDIA 23 0.0004
684 BLOOD POTASSIUM INCREASED 7 0.0004
685 BACK DISORDER 7 0.0004
686 BACTERIAL INFECTION 8 0.0004
687 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 77 0.0004
688 HYPOXIA 15 0.0004
689 RETCHING 9 0.0004
690 ABDOMINAL DISTENSION 44 0.0004
691 BLOOD IRON DECREASED 5 0.0004
692 RED BLOOD CELL COUNT DECREASED 12 0.0004
693 ACCIDENT 5 0.0004
694 SKIN CANCER 9 0.0004
695 PULMONARY FIBROSIS 8 0.0004
696 NEPHROLITHIASIS 19 0.0004
697 SCHIZOPHRENIA 5 0.0004
698 DRUG INEFFECTIVE 540 0.0004
699 KIDNEY INFECTION 8 0.0004
700 INFLAMMATION 21 0.0004
701 SMALL INTESTINAL OBSTRUCTION 5 0.0004
702 TENDON RUPTURE 5 0.0004
703 WITHDRAWAL SYNDROME 17 0.0004
704 ACTIVITIES OF DAILY LIVING IMPAIRED 8 0.0004
705 CEREBROVASCULAR ACCIDENT 68 0.0004
706 HYPERTENSION 85 0.0004
707 NEUROTOXICITY 7 0.0004
708 SPINAL FRACTURE 8 0.0004
709 HOT FLUSH 30 0.0004
710 ECONOMIC PROBLEM 6 0.0004
711 MUSCLE ATROPHY 5 0.0004
712 SEPSIS 44 0.0004
713 INJECTION SITE IRRITATION 5 0.0004
714 BLOOD PRESSURE INCREASED 60 0.0004
715 SURGERY 23 0.0004
716 FEELING HOT 24 0.0004
717 ERECTILE DYSFUNCTION 10 0.0004
718 OEDEMA 21 0.0004
719 PERITONITIS 8 0.0004
720 INTENTIONAL DOSE OMISSION 11 0.0004
721 NERVOUS SYSTEM DISORDER 12 0.0004
722 NAUSEA 304 0.0004
723 ABDOMINAL PAIN 88 0.0004
724 BACK PAIN 87 0.0004
725 JOINT RANGE OF MOTION DECREASED 5 0.0004
726 PRODUCT USE ISSUE 70 0.0004
727 NEURALGIA 9 0.0004
728 CATARACT 22 0.0004
729 INCORRECT DOSE ADMINISTERED 84 0.0004
730 PALLOR 10 0.0004
731 FEELING JITTERY 7 0.0004
732 SLEEP APNOEA SYNDROME 7 0.0004
733 INFECTION 53 0.0004
734 BLOOD POTASSIUM DECREASED 11 0.0004
735 POST PROCEDURAL COMPLICATION 7 0.0004
736 STAPHYLOCOCCAL INFECTION 12 0.0004
737 RESPIRATORY ARREST 10 0.0004
738 HAEMATOCHEZIA 20 0.0004
739 HERNIA 7 0.0004
740 DIVERTICULITIS 10 0.0004
741 STEVENS-JOHNSON SYNDROME 8 0.0004
742 HYPERTENSIVE CRISIS 4 0.0004
743 ROAD TRAFFIC ACCIDENT 15 0.0004
744 CRYING 13 0.0004
745 DYSPNOEA 201 0.0004
746 SKIN REACTION 5 0.0004
747 BLINDNESS UNILATERAL 5 0.0004
748 IMPAIRED DRIVING ABILITY 4 0.0004
749 HAEMOGLOBIN DECREASED 36 0.0004
750 CHOLECYSTECTOMY 4 0.0003
751 COVID-19 61 0.0003
752 ADVERSE EVENT 32 0.0003
753 TASTE DISORDER 7 0.0003
754 COLITIS 13 0.0003
755 NIGHT SWEATS 11 0.0003
756 PAIN IN EXTREMITY 100 0.0003
757 COVID-19 PNEUMONIA 4 0.0003
758 OXYGEN SATURATION DECREASED 19 0.0003
759 THERAPY INTERRUPTED 24 0.0003
760 CHOLECYSTITIS 4 0.0003
761 HAEMORRHAGE INTRACRANIAL 5 0.0003
762 KNEE ARTHROPLASTY 7 0.0003
763 GASTROENTERITIS VIRAL 6 0.0003
764 HYPOAESTHESIA ORAL 5 0.0003
765 OSTEOMYELITIS 6 0.0003
766 PRESYNCOPE 8 0.0003
767 VERTIGO 20 0.0003
768 CEREBRAL INFARCTION 8 0.0003
769 HYPOKALAEMIA 15 0.0003
770 GENERALISED OEDEMA 4 0.0003
771 ANKLE FRACTURE 5 0.0003
772 SEPTIC SHOCK 14 0.0003
773 PRODUCT DISPENSING ERROR 7 0.0003
774 EXTRA DOSE ADMINISTERED 13 0.0003
775 CLOSTRIDIUM DIFFICILE INFECTION 7 0.0003
776 THERAPY PARTIAL RESPONDER 5 0.0003
777 PAIN 196 0.0003
778 VOMITING 150 0.0003
779 CYANOSIS 5 0.0003
780 FLATULENCE 18 0.0003
781 BLOOD URINE PRESENT 6 0.0003
782 GAMMA-GLUTAMYLTRANSFERASE INCREASED 7 0.0003
783 ULCER 5 0.0003
784 ANGINA PECTORIS 9 0.0003
785 MOOD SWINGS 10 0.0003
786 SCIATICA 5 0.0003
787 DRUG ABUSE 26 0.0003
788 CARDIO-RESPIRATORY ARREST 13 0.0003
789 HAEMORRHOIDS 6 0.0003
790 OSTEOARTHRITIS 13 0.0003
791 DYSPEPSIA 30 0.0003
792 HYPOACUSIS 13 0.0003
793 ADVERSE REACTION 4 0.0003
794 JAUNDICE 8 0.0003
795 INTENTIONAL PRODUCT MISUSE 26 0.0003
796 INFLUENZA 33 0.0003
797 CHEST DISCOMFORT 30 0.0003
798 MUSCULOSKELETAL DISCOMFORT 5 0.0003
799 PULMONARY OEDEMA 13 0.0003
800 TOOTH LOSS 6 0.0003
801 HYPOGLYCAEMIA 14 0.0003
802 PROCEDURAL PAIN 8 0.0003
803 FEELING COLD 8 0.0003
804 HAEMOPTYSIS 8 0.0003
805 ABDOMINAL DISCOMFORT 48 0.0003
806 RENAL IMPAIRMENT 24 0.0003
807 HEART RATE DECREASED 10 0.0003
808 BLOOD TEST ABNORMAL 4 0.0003
809 NEUROPATHY PERIPHERAL 27 0.0003
810 DYSGEUSIA 21 0.0003
811 DRUG ERUPTION 5 0.0003
812 THERAPEUTIC RESPONSE DECREASED 17 0.0003
813 THIRST 5 0.0003
814 DISEASE PROGRESSION 33 0.0003
815 GOUT 5 0.0003
816 CARDIAC DISORDER 26 0.0003
817 FAECES DISCOLOURED 6 0.0003
818 COMPLICATION ASSOCIATED WITH DEVICE 4 0.0003
819 GASTROENTERITIS 4 0.0003
820 PYREXIA 94 0.0003
821 SKIN ULCER 7 0.0003
822 FUNGAL INFECTION 9 0.0003
823 SKIN DISORDER 9 0.0003
824 CONJUNCTIVITIS 5 0.0003
825 ABDOMINAL PAIN UPPER 55 0.0003
826 INTENTIONAL OVERDOSE 17 0.0003
827 CHEST PAIN 49 0.0003
828 CORONARY ARTERY DISEASE 8 0.0003
829 PRODUCT AVAILABILITY ISSUE 6 0.0003
830 PULMONARY EMBOLISM 25 0.0003
831 PLEURAL EFFUSION 16 0.0003
832 HEART RATE INCREASED 26 0.0003
833 DRUG WITHDRAWAL SYNDROME 23 0.0003
834 BLOOD CREATININE INCREASED 17 0.0003
835 BLOOD BILIRUBIN INCREASED 7 0.0003
836 THROAT TIGHTNESS 7 0.0003
837 BASAL CELL CARCINOMA 4 0.0003
838 BLOOD PRESSURE SYSTOLIC INCREASED 5 0.0003
839 SWOLLEN TONGUE 8 0.0003
840 MYALGIA 43 0.0003
841 DISABILITY 5 0.0003
842 OVERDOSE 54 0.0003
843 HAEMORRHAGE 26 0.0002
844 PARAESTHESIA 39 0.0002
845 EMOTIONAL DISTRESS 30 0.0002
846 DRUG EFFECT INCOMPLETE 9 0.0002
847 PALPITATIONS 29 0.0002
848 ALANINE AMINOTRANSFERASE INCREASED 15 0.0002
849 IMPAIRED HEALING 8 0.0002
850 OSTEOPOROSIS 10 0.0002
851 ACUTE KIDNEY INJURY 37 0.0002
852 DRUG LEVEL INCREASED 4 0.0002
853 MYOCARDIAL INFARCTION 42 0.0002
854 VISION BLURRED 33 0.0002
855 LIP SWELLING 8 0.0002
856 TINNITUS 11 0.0002
857 SKIN DISCOLOURATION 11 0.0002
858 CHILLS 28 0.0002
859 THROMBOSIS 19 0.0002
860 HEMIPARESIS 4 0.0002
861 SWELLING 22 0.0002
862 ERYTHEMA 48 0.0002
863 IRRITABLE BOWEL SYNDROME 5 0.0002
864 DISEASE RECURRENCE 11 0.0002
865 DRUG ADMINISTRATION ERROR 7 0.0002
866 HERPES ZOSTER 13 0.0002
867 ACUTE RESPIRATORY DISTRESS SYNDROME 4 0.0002
868 ANAEMIA 43 0.0002
869 HEPATOTOXICITY 5 0.0002
870 GALLBLADDER DISORDER 4 0.0002
871 GASTROOESOPHAGEAL REFLUX DISEASE 18 0.0002
872 DIARRHOEA 144 0.0002
873 METABOLIC ACIDOSIS 7 0.0002
874 RHINORRHOEA 14 0.0002
875 FLUID RETENTION 11 0.0002
876 MEDICATION ERROR 12 0.0002
877 JOINT SWELLING 26 0.0002
878 HEPATIC STEATOSIS 4 0.0002
879 DYSPNOEA EXERTIONAL 8 0.0002
880 DRUG DOSE OMISSION 35 0.0002
881 CARDIAC FAILURE CONGESTIVE 17 0.0002
882 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 11 0.0002
883 GLAUCOMA 4 0.0002
884 ASPARTATE AMINOTRANSFERASE INCREASED 11 0.0002
885 ERUCTATION 4 0.0002
886 HAEMATURIA 7 0.0002
887 RENAL FAILURE 27 0.0002
888 ABASIA 5 0.0002
889 RESPIRATORY DISORDER 6 0.0002
890 HEADACHE 125 0.0002
891 LACRIMATION INCREASED 6 0.0002
892 ARTHROPATHY 11 0.0002
893 PRODUCT USE IN UNAPPROVED INDICATION 49 0.0002
894 HAEMATEMESIS 5 0.0002
895 PRODUCT ADHESION ISSUE 7 0.0002
896 INJECTION SITE WARMTH 4 0.0002
897 OFF LABEL USE 170 0.0002
898 INJECTION SITE ERYTHEMA 24 0.0002
899 GASTROINTESTINAL HAEMORRHAGE 16 0.0002
900 ACCIDENTAL OVERDOSE 7 0.0002
901 PRODUCT SUBSTITUTION ISSUE 11 0.0002
902 ARTHRITIS 15 0.0002
903 RENAL FAILURE ACUTE 8 0.0002
904 EAR INFECTION 5 0.0002
905 BURNING SENSATION 13 0.0002
906 FREQUENT BOWEL MOVEMENTS 5 0.0002
907 DEEP VEIN THROMBOSIS 12 0.0002
908 CHRONIC KIDNEY DISEASE 14 0.0002
909 TOXICITY TO VARIOUS AGENTS 31 0.0002
910 LUNG DISORDER 9 0.0002
911 CHOLELITHIASIS 6 0.0002
912 ARTHRALGIA 75 0.0002
913 VIRAL INFECTION 6 0.0002
914 WEIGHT INCREASED 40 0.0002
915 BRONCHITIS 13 0.0002
916 PANCREATIC CARCINOMA 5 0.0002
917 MUSCULOSKELETAL PAIN 9 0.0002
918 RENAL DISORDER 8 0.0002
919 DEVICE MALFUNCTION 12 0.0002
920 INJURY 12 0.0002
921 THROMBOCYTOPENIA 19 0.0002
922 DEVICE EXPULSION 11 0.0002
923 ACUTE MYOCARDIAL INFARCTION 5 0.0002
924 EPISTAXIS 12 0.0002
925 DRY EYE 8 0.0002
926 EYE PAIN 9 0.0002
927 LIVER DISORDER 7 0.0002
928 HEPATITIS 4 0.0002
929 PLASMA CELL MYELOMA 6 0.0002
930 ECZEMA 8 0.0002
931 APPLICATION SITE ERYTHEMA 4 0.0002
932 OROPHARYNGEAL PAIN 14 0.0002
933 NEOPLASM MALIGNANT 10 0.0001
934 NASOPHARYNGITIS 27 0.0001
935 RASH ERYTHEMATOUS 7 0.0001
936 BLOOD GLUCOSE DECREASED 7 0.0001
937 RASH MACULAR 5 0.0001
938 HYPERKALAEMIA 5 0.0001
939 INTERNATIONAL NORMALISED RATIO INCREASED 4 0.0001
940 INCORRECT ROUTE OF DRUG ADMINISTRATION 5 0.0001
941 ELECTROCARDIOGRAM QT PROLONGED 5 0.0001
942 SWELLING FACE 9 0.0001
943 FLUSHING 14 0.0001
944 INTENTIONAL PRODUCT USE ISSUE 12 0.0001
945 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 4 0.0001
946 INJECTION SITE MASS 5 0.0001
947 SKIN IRRITATION 6 0.0001
948 RASH PRURITIC 7 0.0001
949 BLISTER 7 0.0001
950 BLINDNESS 5 0.0001
951 EYE DISORDER 4 0.0001
952 DIABETES MELLITUS 9 0.0001
953 INJECTION SITE SWELLING 9 0.0001
954 GASTRIC DISORDER 4 0.0001
955 RASH 50 0.0001
956 PANCREATITIS 6 0.0001
957 HEPATIC FUNCTION ABNORMAL 4 0.0001
958 MIGRAINE 10 0.0001
959 INJECTION SITE PRURITUS 7 0.0001
960 EYE IRRITATION 6 0.0001
961 PRODUCT QUALITY ISSUE 14 0.0001
962 HYPERSENSITIVITY 19 0.0001
963 NASAL CONGESTION 6 0.0001
964 INJECTION SITE BRUISING 8 0.0001
965 STOMATITIS 6 0.0001
966 SINUSITIS 10 0.0001
967 TREATMENT FAILURE 8 0.0001
968 COMPLETED SUICIDE 8 0.0001
969 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 5 0.0001
970 PRURITUS 35 0.0001
971 INJECTION SITE REACTION 6 0.0001
972 PROSTATE CANCER 7 0.0001
973 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 6 0.0001
974 WHEEZING 5 0.0001
975 SKIN EXFOLIATION 7 0.0001
976 ALOPECIA 16 0.0001
977 NEUTROPENIA 11 0.0001
978 BLOOD GLUCOSE INCREASED 15 0.0001
979 BREAST CANCER 7 0.0001
980 HEPATIC ENZYME INCREASED 5 0.0001
981 DEPENDENCE 4 0.0001
982 URTICARIA 12 0.0001
983 SKIN BURNING SENSATION 5 0.0001
984 DRY SKIN 9 0.0001
985 DRUG DOSE OMISSION BY DEVICE 5 0.0001
986 ASTHMA 7 0.0001
987 INFLUENZA LIKE ILLNESS 5 0.0001
988 PRODUCT STORAGE ERROR 5 0.0001
989 PLATELET COUNT DECREASED 6 0.0001
990 DRUG DEPENDENCE 9 0.0001
991 INJECTION SITE HAEMORRHAGE 4 0.0001
992 WHITE BLOOD CELL COUNT DECREASED 5 0.0000
993 INJECTION SITE PAIN 12 0.0000
994 NO ADVERSE EVENT 7 0.0000